Protocol

Objectives:
This study is designed to evaluate the effectiveness of treatment of residual amblyopia in children ages 3 to <10 years with visual acuity of 20/32 to 20/63 in the amblyopic eye. The study is a randomized clinical trial comparing intensive treatment (42 hours daily patching plus daily atropine) with a control group that will have rapid weaning of existing treatment followed by spectacle correction only (if needed). The primary objective is to determine if intensive treatment will improve visual acuity in patients with residual amblyopia.